Search - tctmd.com

January 25, 2021

News Daily News

Vitamin D, Calcium, Other Vitamins, and Supplements Do Not Prevent CVD

January 25, 2021

Excluded from Pivotal Trials, Low-risk Complex Patients Warrant Caution

News Daily News

Excluded From Pivotal Trials, Low-risk Complex AS Patients Warrant Caution

January 22, 2021

News Daily News

Echo Screening for Rheumatic Heart Disease in Kids Gets a Boost

Caitlin E. Cox

January 21, 2021

News Daily News

FDA Approves Vericiguat for High-risk Patients With HF

January 20, 2021

News Daily News

Hospitalization for HF After Acute MI More Common in Women Than Men

January 15, 2021

News Daily News

CAC Screening Cost-effective for Statin Decisions in Hereditary CAD

January 14, 2021

News Daily News

REPLACE COVID Bolsters Advice to Continue RAAS Inhibitors in COVID-19 Patients

Todd Neale

January 13, 2021

FDA Says Newer Paclitaxel Data Is ‘Comforting’ but Limited

News Daily News

FDA Says Newer Paclitaxel Data Are ‘Comforting’ but Limited

January 12, 2021

News Features

Low Numbers and ‘Anecdata’: Shoddy Research Rode COVID-19’s First Wave

January 11, 2021

News Daily News

ACC’s HFrEF Update Includes ARNI, SGLT2 Inhibitor Trials Plus Tips for Care

January 11, 2021

News Daily News

COVID-19: TCTMD’s Daily Dispatch for January

Todd Neale

January 01, 2021

News Opinion CV Team Dispatch

January 2021 News Roundup

January 01, 2021

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for December 2020

December 31, 2020

News CV Team Pro

NorthShore University Health System

December 30, 2020

News Opinion Editor's Corner

Envision Change: A Different Future for Cardiology, Medicine, Research, and Health

December 29, 2020

News Opinion Editor's Corner

The Biggest News of 2020: TCTMD’s Top 10

December 28, 2020

News Daily News

FDA Passes on Inclisiran, Citing Manufacturing Site Problems

December 23, 2020

News Daily News

ACC Issues New Guidance Around Antithrombotic Choices in A-fib, VTE

Todd Neale

December 22, 2020

News Daily News

ACE Inhibitors, ARBs: Still No Link to COVID-19 Risks, New Analyses Show